Ten Arizona startups, including bioscience companies, brought in $71.14 million in investments during the first quarter of 2017, led by Centauri Health Solutions, with $50.25 million in funding from Silversmith Capital Partners, according to the MoneyTree venture-capital report.

The family members of 7-year-old Hollis Doherty, who passed away this year after a battle with a rare form of brain cancer, have donated $30,000 to the Translational Genomics Research Institute for scientists and physicians to study the disease.

The results from a two-year study on Northern Arizona University football players, in which physicians monitored hits from afar, showed that a sideline tech and the physician agreed on diagnosing a concussion.

Nearly 15 years after its introduction to the Tempe campus, ASU’s Biodesign Institute is changing and expanding with a new director and construction underway on its third building, which is expected to be finished in 2018.

Jeffrey Trent, president and research director at Translational Genomics Research Institute, writes that precision medicine could revolutionize patient care as we know it, and this year Phoenix’s TGen is becoming a larger player in it.

Jeff Stevens, CEO of Western Refining Logistics and a University of Arizona graduate who served on the Presidential Search Advisory Committee, writes that new UA president Dr. Robert Robbins’ charge is nothing less than to ensure UA achieves new heights in academic discovery and achievement on behalf of Arizonans and future generations of students.

Dr. Robert C. Robbins, who will begin his role as University of Arizona president on June 1, will be paid $988,000 a year in salary and benefits as part of his three-year contract approved by the Arizona Board of Regents.

An interview with the Goldwater Institute and a Valley surgeon discusses the Free Speech in Medicine Act, which is intended to give drug companies the freedom to tell physicians and other medical professionals about so-called off-label uses for approved pharmaceuticals.